Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you consider consolidative RT in patients with metastatic bladder cancer after near complete response after Keytruda?
Answer from: Radiation Oncologist at Community Practice
Generally, no I wouldn't, as I can't quantify the risk-to-benefit ratio given the paucity of data.
Sign In
or
Register
to read more
20304
Related Questions
Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?
Do you utilize daily enemas for patients undergoing prostate SBRT?
How do you manage prostatic adenocarcinoma after a subtotal resection?
What are your institution's standard liquid intake instructions for prostate cancer patients going through definitive external beam radiation?
What is your radiation approach/details for regionally involved prostate cancer (N1)?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
How can you manage a patient with bilateral PCNs that requires Pluvicto administration?
How does the presence of indeterminate lymphadenopathy on PSMA PET scan alter your management of unfavorable intermediate-risk prostate cancer?
With the recent BART, trial how would you manage a positive ureter margin that is now part of the urostomy?
How often do you utilize intrafraction motion tracking when treating prostate cancer?